Nachrichten und Videos - ITEOS THERAPEUTICS INC. - Englisch - Seite 4

Sie betrachten derzeit alle Börsennachrichten von Instrument ITEOS THERAPEUTICS INC. in allen Märkten in Englisch.

> Nachrichten GlobeNewsWire hat eine neue Nachricht veröffentlicht.

iTeos to Present at Piper Sandler 32nd Annual Healthcare Conference • • GlobeNewsWire • Aktien

CAMBRIDGE, Mass. and GOSSELIES, Belgium, Nov. 23, 2020 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, today announced that management will present at the Piper Sandler 32 nd Annual Healthcare Conference, taking place December 1 – 3, 2020. The fireside chat is now available for registered attendees to view...

Danke Chart

> Nachrichten GlobeNewsWire hat eine neue Nachricht veröffentlicht.

iTeos Reports Third Quarter 2020 Financial Results and Provides Business Update • • GlobeNewsWire • Aktien

- Patient enrol l ment in Phase 1/2 stud ies of EOS-850 A 2A R antagonist and EOS-448 FCγ R-enabled anti-TIGIT antibody continue s with initial data expected in 1H21 - - Strong cash position to support ongoing clinical development and operations into 2023 - CAMBRIDGE, Mass. and GOSSELIES, Belgium, Nov. 12, 2020 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly...

Danke Chart

> Nachrichten GlobeNewsWire hat eine neue Nachricht veröffentlicht.

iTeos Appoints Matthew Roden, Ph.D. to Board of Directors • • GlobeNewsWire • Aktien

CAMBRIDGE, Mass. and GOSSELIES, Belgium, Nov. 12, 2020 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, today announced the appointment of Matthew Roden, Ph.D., to its Board of Directors. Dr. Roden joins the Board as a Partner of MPM Capital and will replace Ansbert Gadicke, M.D. “Matt will be a tremendous...

Danke Chart

> Nachrichten GlobeNewsWire hat eine neue Nachricht veröffentlicht.

iTeos to Participate in Upcoming Investor Conferences in September • • GlobeNewsWire • Aktien

CAMBRIDGE, Mass. and GOSSELIES, Belgium, Sept. 08, 2020 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, today announced that management will participate in two upcoming virtual investor conferences in September. Citi’s 15 th Annual BioPharma Virtual Conference Date: Wednesday, September 9 – Thursday, September...

Danke Chart

> Nachrichten GlobeNewsWire hat eine neue Nachricht veröffentlicht.

iTeos Reports Second Quarter 2020 Financial Results and Provides Business Update • • GlobeNewsWire • Aktien

- July 2020 IPO provided $210.6 million in net proceeds and extends cash runway into 2023 - - EOS-850 A 2A R antagonist and EOS-448 FC g R-enabled anti-TIGIT antibody continue to progress in clinical trials - CAMBRIDGE, Mass. and GOSSELIES, Belgium, Sept. 01, 2020 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients,...

Danke Chart